Magnetic field setups in zero field (a) and vertically alternating field (b). by Xuegang Mao (599968)

Subjects:

Decreased hypotaurine levels within cells lacking the ADO gene in U251 cells. by Hong Tian (169626)

Differences in abundance in liver of <i>Fmo5</i>^<i>-/-</i> and WT mice of products of microbial and host-conjugation reactions. by Ian R. Phillips (5074121)

Multivariable Linear Regression Model of the Residents P-V Fit score^a. by Yaotian Fan (5917766)

Subjects:

Whole brain volume change over 5 years using the SIENA pipeline. by Renxin Chu (5169857)

Effect of squalene on antioxidative parameters from the three experimental models. by Clara Gabás-Rivera (613994)

Liver expression of LDLR and ABCA1 protein in mice with hepatic MTP knockdown. by Stephanie M. Marshall (223125)

Hepatic and intestinal MTP expression following MTP ASO treatment. by Stephanie M. Marshall (223125)

Descriptive statistics (mean [standard deviation] or % [sample size]) for study variables analyzed in the current study. by Angelina R. Sutin (9216456)

Plasma lipoprotein cholesterol and apoliporotein distribution following MTP knockdown. by Stephanie M. Marshall (223125)

Hepatic secretion of lipid and apoB with MTP knockdown. by Stephanie M. Marshall (223125)

Decreased numbers of <i>dicer</i>^<i>CKO</i> P14 effector cells demonstrate an intrinsic role of Dicer during CD8 T cell expansion. by Florian M. Baumann (3119772)

γHV68-IκBαM–Infected Mice Have Decreased Splenic Latency at Later Timepoints after Intranasal Infection that Is Not Altered by Inhibiting Lytic Replication by Laurie T Krug (68237)

Beverage Containing Dispersible Yeast β-Glucan Decreases Cold/Flu Symptomatic Days After Intense Exercise: A Randomized Controlled Trial by Eunice Mah (5918042)

“…Participants completed a daily online survey assessing compliance, training status, and URTI symptoms. …”

Geometric mean concentrations of 5 most abundant PCDD/F congeners and the sum of other congeners (A), and PCDD and PCDF TEQ (C) in different study areas during the first (1972–1986... by Matti Viluksela (321291)

The <i>P[syt^P-L]</i> mutation decreases the Ca²⁺ affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

“…<p>(A) Mean EJP amplitudes from <i>+/-;P[syt^WT]/+</i> (filled black circles) and <i>+/-;P[syt^P-L]/+</i> (filled red circles) larvae at Ca²⁺ levels ranging from 0.05 mM—5.0 mM. …”

Kaplan-Meier for decreases in CD4 T-cells (A) and rebound of viral load (VL) (B) in HIV-infected patients after treatment interruption by Elena Seoane (90182)

RMSD graphs for the backbone of WT PARG1, I845V and T622M mutants. by Zen Kouchi (14898435)

NR4A1 expression does not decrease after inhibition of p38, JNK and Src pathways. by Glenda Eger (636934)

Pravastatin increases cyclin D1 expression but prevents passage through S-Phase in NSPCs. by Ross A. Carson (5184512)